The top pick for 2025 is rescheduling to Schedule III, not full legalization. That call rests on four criteria: whether the change needs a new act of Congress, how far the paperwork has already traveled, whether federal criminal status actually changes, and how much it changes daily convenience for patients, consumers, and licensed sellers. Congressional legalization is the second option, executive descheduling is third, and the state patchwork status quo is the baseline that none of the others has replaced.
The short answer
Marijuana will most likely stay federally illegal through 2025. Federal law still lists cannabis as a Schedule I controlled substance, and that listing has not changed. Two events could move the answer: the Drug Enforcement Administration finalizing a rescheduling rule, or Congress passing a legalization bill. Rescheduling to Schedule III would change tax and research rules while leaving federal prohibition in place. Full legalization needs Congress, and the votes have not existed in the Senate in recent sessions. As of early 2025, 24 states and the District of Columbia allow adult use, and nearly 40 states permit some form of medical cannabis. State law, not federal law, is what most people actually experience at the counter or on a delivery app.
federal penalty for possession of cannabis
Option 1: Rescheduling to Schedule III (top pick)
This is the most advanced process on the board. Health and Human Services recommended Schedule III in 2023, the DEA issued a proposed rule in 2024, and an administrative hearing before an administrative law judge carried into 2025. A final rule can still be delayed, revised, or challenged in court.
- Pros: achievable through agency rulemaking instead of a floor vote; would remove the 280E tax burden that hits state-licensed operators; would give federal recognition to medical use; would loosen research barriers and reduce banking friction for some institutions.
- Cons: Schedule III is still a controlled substance, so federal possession stays illegal; no federal licensing system appears; no legal interstate commerce; state-by-state rules and travel risk remain; litigation can push a final rule past 2025.
Best for: patients, clinicians, researchers, and operators carrying large federal tax bills. It is not a fix for a customer who wants to buy across state lines or pay by ordinary credit card everywhere.
how federal law affects dispensary banking
Option 2: Executive descheduling or enforcement discretion
A president cannot legalize cannabis with a memo, but the executive branch sets enforcement priorities. The Cole Memo told prosecutors to leave state-legal programs alone, and it was rescinded in 2018. Simple-possession pardons issued in 2022 and 2023 show the limits of the tool: they signal policy and clear some records without changing the statute.
- Pros: fast policy signal; shields state-legal programs from most federal prosecution; can be paired with pardons and clemency; needs no congressional vote.
- Cons: reversible by the next administration; no tax relief; no banking fix; no change to the controlled substances list or federal criminal code.
Best for: licensed operators and consumers in legal states who want a lower-risk status quo. It does not open interstate trade, so it is a holding pattern rather than a settlement.
Option 3: Congressional legalization
Bills such as the MORE Act, the Cannabis Administration and Opportunity Act, STATES 2.0, and the SAFER Banking Act have all been introduced in recent sessions. The MORE Act passed the House twice and died in the Senate. CAOA never received a vote. SAFER Banking stalled despite bipartisan support. Most of these need 60 Senate votes.
- Pros: the only durable route to actual federal legality for adults; can set federal tax, banking, and interstate commerce rules in one statute; harder to reverse than an agency rule.
- Cons: high vote threshold; committee bottlenecks; 2025 majorities make passage unlikely; state programs would still need time to adapt to federal standards.
Best for: investors, banks, and multi-state operators who need certainty before committing capital. If you are planning a 2025 budget, plan for no federal legalization.
Option 4: Status quo with a state patchwork
This is the default outcome and the most probable one for the year. Federal prohibition stays, states keep setting their own rules, and the practical map keeps shifting neighborhood by neighborhood.
- Pros: predictable for existing operators; states keep expanding access, delivery, and curbside pickup; consumers in legal states see little disruption.
- Cons: no interstate commerce; cash-heavy retail; uneven testing and labeling rules; travel and possession risk across state lines; federal possession remains a federal offense.
Best for: consumers and convenience-focused retailers already operating under state licenses. Judge your exposure by the state you are in, not by federal headlines.
Criteria that decide whether an outcome counts as legal
- Does it change the federal statute, or only an agency rule?
- Does it survive a change of administration?
- Does it alter tax treatment and banking access?
- Does it change what a customer can buy, order, or have delivered?
By these tests, rescheduling scores on tax and research, fails on criminal status, and is only partly durable. Congressional legalization scores highest on durability but is the least likely in 2025. Executive action scores low on durability and does nothing for taxes. The status quo scores zero on change and high on predictability.
Why convenience now drives the verdict
For most households, the legalization question is measured in minutes and payment options rather than in statute books. Delivery windows, curbside lanes, online pre-order, wait times, and whether a debit card works matter more than the schedule number on a federal list. Federal rules shape those details from a distance: banking access determines whether card payments run smoothly, tax rules determine what delivery can cost, and interstate commerce rules determine whether supply can cross state lines. Until federal law changes, convenience improves state by state, which means the experience of legal cannabis in 2025 will depend heavily on the zip code.
Recommendation by situation
Patients and researchers should watch the DEA docket, since Schedule III is the realistic 2025 win. Operators should plan for the patchwork and treat rescheduling as a tax event, not a legalization event. Investors and lenders should assume no federal legalization this year and price in continued banking friction. Consumers should follow state rules, because that is where delivery, curbside pickup, and product variety are actually decided.